Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Cytomegalovirus

Cytomegalovirus

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Cytomegalovirus

10 trials tracked for Cytomegalovirus: 5 in phase 3 or 4 and 3 with published results. The most-cited published study has 171 citations.

10Trials tracked
5Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 1 Phase 3 4 Phase 2 4 Other / NA 1
  1. Phase 4 CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") Completed · 171 cited
  2. Phase 3 Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040) Completed · 100 cited
  3. Phase 3 MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042) Completed · 4 cited
  4. Phase 3 A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045) Completed
  5. Phase 3 Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections Completed
  6. Phase 2 Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients Completed
Show 4 more trials
  1. Phase 2 Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation Completed
  2. Phase 2 Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults Completed
  3. Phase 2 Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss Completed
  4. N/A Dried Blood Spot Testing of CMV Detection in HCT Recipients Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review of artesunate for cytomegalovirus in immunocompromised patients
Infectious Disease Meta-analysis
Systematic review of artesunate for cytomegalovirus in immunocompromised patients A Malaria Drug Shows Promise Against a Common Virus
This systematic review synthesizes evidence from 46 studies regarding artesunate for cytomegalovirus in immunocompromised individuals. The a…
A well-known malaria drug called artesunate may offer a new weapon against a common virus that causes serious harm in people with weakened i…
Frontiers May 7, 2026